Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Anaconda Biomed is a medical device start-up that develops the next generation of catheters to perform efficient mechanical thrombectomies.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Ousia Pharma focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity.
HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.
XII Medical provides minimally invasive technology for obstructive sleep apnea.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Omega Funds has invested in 82 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Omega Funds's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Biopharma. The firm invests across 19 different industry categories.
Among tracked funding rounds, BBOT received $200.0M in a Venture - Series Unknown round. Omega Funds's total known invested capital is $7.9B.
Omega Funds's average investment size is $96.5M across its portfolio of 82 companies.
Recent Omega Funds portfolio additions include Anaconda BioMed, Beta Bionics, Vaderis Therapeutics, Editas Medicine, Sana Biotechnology. These companies were founded in 2020 or later.